Zobrazeno 1 - 10
of 1 012
pro vyhledávání: '"HEREGULIN"'
Autor:
Raluca-Ioana Stefan-van Staden, Oana-Raluca Musat, Damaris-Cristina Gheorghe, Ruxandra-Maria Ilie-Mihai, Catalina Cioates Negut, Paula Sfirloaga
Publikováno v:
Talanta Open, Vol 6, Iss , Pp 100151- (2022)
Microsensors based on the physical immobilization of oleamides (N-(pyridine-3-yl-methyl) oleamide, and N-(2-mercapto-1H-benzo[d]imidazole-5-yl) oleamide) on paste containing nanographene decorated with spheroidal Cu were proposed for the molecular re
Externí odkaz:
https://doaj.org/article/c238253403094445b4ed8d94c0739eb3
Autor:
Hanna Huebner, Christian M. Kurbacher, Geoffrey Kuesters, Andreas D. Hartkopf, Michael P. Lux, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans Tesch, Lothar Häberle, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Matthias Ruebner, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Hans-Christian Kolberg, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Johannes Ettl
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Eligibility criteria are a critical part of clinical trials, as they define the patient population under investigation. Besides certain patient characteristics, clinical trials often include biomarker testing for eligibility. Howe
Externí odkaz:
https://doaj.org/article/3595f6bd2f1948ae89b5ca12ff495d0f
Publikováno v:
Micromachines, Vol 13, Iss 10, p 1749 (2022)
Human epidermal growth factor receptor-3, human epidermal growth factor-receptor-4, and heregulin-α are some of the biomarkers related to gastric cancer currently being used for early detection, personalized treatment, and evaluation of the efficien
Externí odkaz:
https://doaj.org/article/a2b6aad0c0964032b19692b2d17d2d90
Autor:
Jenke, Robert, Holzhäuser-Rein, Miriam, Mueller-Wilke, Stefanie, Lordick, Florian, Aigner, Achim, Büch, Thomas
MET-amplified gastric cancer cells are extremely sensitive to MET inhibition in vitro, whereas clinical efficacy of MET inhibitors is disappointing. The compensatory activation of other oncogenic growth factor receptors may serve as an underlying mec
Externí odkaz:
https://ul.qucosa.de/id/qucosa%3A88726
https://ul.qucosa.de/api/qucosa%3A88726/attachment/ATT-0/
https://ul.qucosa.de/api/qucosa%3A88726/attachment/ATT-0/
Publikováno v:
The Journal of Cell Biology, 2002 Jun 01. 157(6), 929-939.
Externí odkaz:
https://www.jstor.org/stable/1621057
Autor:
Laura Salvadori, Sara Chiappalupi, Iva Arato, Francesca Mancuso, Mario Calvitti, Maria Cristina Marchetti, Francesca Riuzzi, Riccardo Calafiore, Giovanni Luca, Guglielmo Sorci
Publikováno v:
Biomolecules, Vol 11, Iss 10, p 1504 (2021)
Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in DMD gene translating in lack of functional dystrophin and resulting in susceptibility of myofibers to rupture during contraction. Inflammation and fibrosis are critical h
Externí odkaz:
https://doaj.org/article/a2642a15fa714653be3a2d4d29f9ef18
Autor:
Sorin Sebastian Gheorghe, Catalina Cioates Negut, Marius Badulescu, Raluca Ioana Stefan-van Staden
Publikováno v:
Life, Vol 11, Iss 9, p 894 (2021)
A composite material comprised of graphene nanoplatelet and silver particles (GNPs–AgPs) was used for the deposition of GNPs–AgPs’ nanofilms with cold plasma on silk. α-Cyclodextrin was used as a modifier of the active surface of the disposabl
Externí odkaz:
https://doaj.org/article/8a73c25543cf4f7d9cf3e4971c7f2ec3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jeanne Mendell, Daniel J. Freeman, Wenqin Feng, Thore Hettmann, Matthias Schneider, Sabine Blum, Jens Ruhe, Johannes Bange, Kenji Nakamaru, Shuquan Chen, Zenta Tsuchihashi, Joachim von Pawel, Catherine Copigneaux, Robert A. Beckman
Publikováno v:
EBioMedicine, Vol 2, Iss 3, Pp 264-271 (2015)
Background: During early clinical development, prospective identification of a predictive biomarker and validation of an assay method may not always be feasible. Dichotomizing a continuous biomarker measure to classify responders also leads to challe
Externí odkaz:
https://doaj.org/article/7234004e5d4f47c7ab14202b186df656